Table 1.

Baseline demographic and clinical characteristics across the three treatment arms

Variable	LR-PRP (n =19)	LP-PRP (n =20)	iPRF (n =18)
Male/Female (n)	09-Oct	13-Jul	11-Jul
Unilateral/Bilateral (n)	Apr-15	Mar-17	May-13
Age (years), mean±SD	49.89±6.65	45.40±5.83	48.33±7.82
BMI (kg/m2), mean±SD	27.52±3.33	29.11±2.80	25.50±3.83
Symptom duration (mo), mean±SD	7.68±3.46	7.75±2.86	8.06±2.69
Baseline plantar fascia thickness (mm)	5.39±0.60	5.71±0.53	5.54±0.60

BMI: Body mass index, LR-PRP: Leukocyte-rich platelet-rich plasma, iPRF: Injectable platelet-rich fibrin